Discover
XCUR
Exicure, Inc.
1.98
1 x 4.05
1 x 2.95
bid
ask
-
0.10
4.81%
1 @ 04:00 PM
1.98 +0.00 (0.00%)
| Ytd | -63.47% | |
| 1y | -67.54% |
1.94
day range
2.08
1.71
52 week range
9.50
| Open | 2.02 | Prev Close | 2.08 | Low | 1.94 | High | 2.08 | Mkt Cap | 12.62M |
| Vol | 37.89K | Avg Vol | 25.73K | EPS | -1.57 | P/E | N/A | Forward P/E | -25.38 |
| Beta | 1.28 | Short Ratio | 0.19 | Inst. Own | 4.29% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.97 | 200-d Avg | 4.19 | 1yr Est | 2.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-08-13 | 2024-06 | 0 | -0.35 | N/A | N/A |
| 2024-06-17 | 2024-03 | 0 | -0.5 | N/A | N/A |
| 2024-06-06 | 2023-12 | 0 | -0.65 | N/A | N/A |
| 2024-05-16 | 2023-09 | 0 | N/A | N/A | N/A |
| 2023-08-11 | 2023-06 | 0 | -3.4 | N/A | N/A |
| 2023-07-14 | 2023-03 | 0 | -3.5 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2022-08-16 | Chardan Capital | Upgrade | Neutral |
Profile
Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2022-12-14 | CBI USA, INC. | Beneficial Owner of more than 10% of a Class of Security | 4.22M | Purchase |
| 2024-02-28 | DGP CO., LTD. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
| 2021-11-14 | FELTNER DOUGLAS E | Officer | 15.00K | Stock Award(Grant) |
| 2021-12-20 | GATES VENTURES, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | 5.06M | Sale |
| 2021-11-14 | GILJOHANN DAVID A. | Chief Executive Officer | 38.67K | Stock Award(Grant) |
| 2020-06-11 | MIRKIN CHAD A | Director and Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Carlyle Group Inc. | 56.33K | 1.10M | 2.16% |
| 2024-09-29 | HRT Financial LP | 14.48K | 282.94K | 0.56% |
| 2024-09-29 | Northwestern University | 10.43K | 203.80K | 0.40% |
| 2024-09-29 | UBS Group AG | 9.59K | 187.35K | 0.37% |
| 2024-09-29 | Tower Research Capital LLC (TRC) | 1.41K | 27.63K | 0.05% |
| 2024-09-29 | Morgan Stanley | 645.00 | 12.60K | 0.02% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Extended Market Index Fund | 8.02K | 156.69K | 0.31% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 4.17K | 81.42K | 0.16% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 1.53K | 29.84K | 0.06% |
| 2024-10-30 | Fidelity Total Market Index Fund | 896.00 | 17.51K | 0.03% |
| 2024-09-29 | Master Investment Portfolio-Diversified Equity Master Portfolio | 35.00 | 683.00 | 0.00% |
Split
| Split | Date |
|---|---|
| 1 : 5 | 2024-08-28 |
| 1 : 30 | 2022-06-30 |